Bank of Montreal Can Has $191.81 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Bank of Montreal Can lessened its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 12.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 984,606 shares of the company's stock after selling 136,525 shares during the quarter. Bank of Montreal Can owned 0.22% of Zoetis worth $191,811,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Mizuho Securities USA LLC boosted its holdings in shares of Zoetis by 13,726.9% in the third quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company's stock valued at $950,524,000 after buying an additional 4,829,815 shares during the period. Sarasin & Partners LLP boosted its holdings in shares of Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company's stock valued at $390,682,000 after buying an additional 1,904,899 shares during the period. Swedbank AB acquired a new position in shares of Zoetis in the first quarter valued at approximately $210,815,000. International Assets Investment Management LLC boosted its holdings in shares of Zoetis by 41,235.7% in the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company's stock valued at $183,652,000 after buying an additional 937,700 shares during the period. Finally, Marshall Wace LLP boosted its holdings in shares of Zoetis by 7,608.6% in the second quarter. Marshall Wace LLP now owns 835,684 shares of the company's stock valued at $144,874,000 after buying an additional 824,843 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ZTS. Piper Sandler upped their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an "overweight" rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. BTIG Research increased their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a "buy" rating in a report on Monday, August 12th. Argus upgraded shares of Zoetis to a "strong-buy" rating in a report on Friday, August 9th. Finally, Stifel Nicolaus increased their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a "buy" rating in a report on Wednesday, September 18th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has an average rating of "Buy" and an average target price of $221.44.

Zoetis Stock Performance

NYSE ZTS traded down $3.01 on Tuesday, hitting $175.70. 2,539,501 shares of the stock were exchanged, compared to its average volume of 2,551,124. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The business's fifty day moving average is $184.91 and its 200 day moving average is $180.84. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The company has a market capitalization of $79.27 billion, a PE ratio of 33.03, a P/E/G ratio of 2.71 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company's quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.36 earnings per share. Research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis's payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.